To include your compound in the COVID-19 Resource Center, submit it here.

No FDA biosimilars applications filed

FDA has not received any applications to market a biosimilar version of an approved biologic

Read the full 159 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE